The Multidimensional Health Assessment Questionnaire (MDHAQ) is a patient-reported outcome (PRO) tool that includes the Routine Assessment of Patient Index Data 3 (RAPID3), an index that can be calculated at the point of care. The objective of this study was to perform psychometric analyses of MDHAQ/RAPID3 to study its measurement properties in systemic lupus erythematosus (SLE).
Methods
The MDHAQ was completed by 161 SLE patients in routine care, along with LupusPRO (a disease-specific PRO). The SLE disease-specific activity index (SELENA-SLEDAI) and damage (SDI) were assessed. Data from 70 patients with rheumatoid arthritis who had completed MDHAQ during their routine medical care were used as controls to compare the results of Physical Function (FN) domain exploratory factor analysis. Internal consistency reliability (ICR) for FN items was calculated using Cronbach's α. Validity of MDHAQ/RAPID3 was evaluated for content validity and construct validity. Responsiveness of the RAPID3 to changes in disease activity anchors was assessed.
Results
The ICR of the 10 physical function items on Cronbach's α was 0.88. Exploratory factor analysis revealed cross-loadings of three FN items. RAPID3 showed a strong correlation with LupusPRO health-related quality of life score (rho –0.68 (p < 0.001)), indicating convergent validity. RAPID3 scores did not correlate with disease activity indices or SDI. After adjustment for fibromyalgia status, a weak correlation with the Physician's Global Assessment (PGA) (rho = 0.31, p = 0.008) was noted. RAPID3 could differentiate between SLE patients based on flare status. RAPID3 was not responsive to changes in PGA, SELENA-SLEDAI or SELENA-Flare Index.
Conclusions
MDHAQ/RAPID3 has fair reliability and validity in SLE.
SiegelMLeeSL. The epidemiology of systemic lupus erythematosus. Semin Arthritis Rheum1973; 3: 1–54.
2.
UrowitzMBGladmanDDAbu-ShakraMFarewellVT. Mortality studies in systemic lupus erythematosus. Results from a single center. III. Improved survival over 24 years. J Rheumatol1997; 24: 1061–1065.
3.
JollyM. How does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?. J Rheumatol2005; 32: 1706–1708.
4.
BurckhardtCSArchenholtzBBjelleA. Quality of life of women with systemic lupus erythematosus: A comparison with women with rheumatoid arthritis. J Rheumatol1993; 20: 977–981.
5.
DuaABToumaZTolozaSJollyM. Top 10 recent developments in health-related quality of life in patients with systemic lupus erythematosus. Curr Rheumatol Rep2013; 15: 380.
6.
AggarwalRWilkeCTPickardASet al.Psychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosus. J Rheumatol2009; 36: 1209–1216.
7.
FonsecaRBernardesMTerrosoGde SousaMFigueiredo-BragaM. Silent burdens in disease: Fatigue and depression in SLE. Autoimmune Dis2014; 2014: 790724.
8.
McElhoneKAbbottJTehLS. A review of health related quality of life in systemic lupus erythematosus. Lupus2006; 15: 633–643.
9.
CastrejónIYaziciYSamuelsJLutaGPincusT. Discordance of global estimates by patients and their physicians in usual care of many rheumatic diseases: Association with 5 scores on a Multidimensional Health Assessment Questionnaire (MDHAQ) that are not found on the Health Assessment Questionnaire (HAQ). Arthritis Care Res2014; 66: 934–942.
10.
McElhoneKAbbottJShelmerdineJet al.Development and validation of a disease-specific health-related quality of life measure, the LupusQol, for adults with systemic lupus erythematosus. Arthritis Rheum2007; 57: 972–979.
11.
LeongKPKongKOThongBYet al.Development and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL). Rheumatology (Oxford)2005; 44: 1267–1276.
12.
DowardLCMcKennaSPWhalleyDet al.The development of the L-QoL: A quality-of-life instrument specific to systemic lupus erythematosus. Ann Rheum Dis2009; 68: 196–200.
JollyMUtsetTO. Can disease specific measures for systemic lupus erythematosus predict patients health related quality of life?. Lupus2004; 13: 924–926.
15.
Romero-DiazJIsenbergDRamsey-GoldmanR. Measures of adult systemic lupus erythematosus: Updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Res (Hoboken)2011; 63(Suppl 11): S37–S46.
16.
FriesJFSpitzPKrainesRGHolmanHR. Measurement of patient outcome in arthritis. Arthritis Rheum1980; 23: 137–145.
17.
TanEMCohenASFriesJFet al.The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271–1277.
18.
HochbergMC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40: 1725.
19.
PincusT. Are patient questionnaire scores as “scientific” as laboratory tests for rheumatology clinical care?. Bull NYU Hosp Jt Dis2010; 68: 130–139.
20.
PincusTSwearingenCWolfeF. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): Assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum1999; 42: 2220–2230.
21.
NavarraSVTanangunanRMMikolaitis-PreussRAKosinskiMBlockJAJollyM. Cross-cultural validation of a disease-specific patient-reported outcome measure for lupus in Philippines. Lupus2013; 22: 262–267.
22.
JollyMTolozaSBlockJet al.Spanish LupusPRO: Cross-cultural validation study for lupus. Lupus2013; 22: 431–436.
23.
Bourré-TessierJClarkeAEMikolaitis-PreussRAet al.Cross-cultural validation of a disease-specific patient-reported outcome measure for systemic lupus erythematosus in Canada. J Rheumatol2013; 40: 1327–1333.
24.
BombardierCGladmanDDUrowitzMBCaronDChangCH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum1992; 35: 630–640.
25.
SchnedESGlicksteinSLDoyleMA. Derivation of the SLEDAI. Arthritis Rheum1993; 36: 877–878.
26.
GladmanDGinzlerEGoldsmithCet al.The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum1996; 39: 363–369.
27.
HaysRDAndersonRRevickiD. Psychometric considerations in evaluating health-related quality of life measures. Qual Life Res1993; 2: 441–449.
28.
Batista-FoguetJMCoendersGAlonsoJ. Confirmatory factor analysis. Its role on the validation of health related questionnaires [article in Spanish]. Med Clin (Barc)2004; 122(Suppl 1): 21–27.
29.
CronbachLJ. Coefficient alpha and the internal structure of tests. Psychometrika1951; 16: 297–334.
30.
SpearmanC. The proof and measurement of association between two things. By C. Spearman, 1904. Am J Psychol1987; 100: 441–471.
31.
WittPLMcGrainP. Comparing two sample means t tests. Phys Ther1985; 65: 1730–1733.
32.
AskanaseADCastrejónIPincusT. Quantitative data for care of patients with systemic lupus erythematosus in usual clinical settings: A patient Multidimensional Health Assessment Questionnaire and physician estimate of noninflammatory symptoms. J Rheumatol2011; 38: 1309–1316.
33.
ThumbooJStrandV. Health-related quality of life in patients with systemic lupus erythematosus: An update. Ann Acad Med Singapore2007; 36: 115–122.
34.
AnnapureddyNGiangrecoDShettyNJollyM. Comparison of physical function in SLE and RA using MDHAQ. Ann Rheum2014; 73(Suppl 2): 1158–1159.
35.
PincusTSokkaTKautiainenH. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum2005; 52: 1009–1019.
36.
StrandVGladmanDIsenbergDPetriMSmolenJTugwellP. Outcome measures to be used in clinical trials in systemic lupus erythematosus. J Rheumatol1999; 26: 490–497.
37.
KuriyaBGladmanDDIbañezDUrowitzMB. Quality of life over time in patients with systemic lupus erythematosus. Arthritis Rheum2008; 59: 181–185.
38.
NewmanEDLerchVJonesJBStewartW. Touchscreen questionnaire patient data collection in rheumatology practice: Development of a highly successful system using process redesign. Arthritis Care Res (Hoboken)2012; 64: 589–596.
39.
CastrejónIPincusTWendlingDDougadosM. Responsiveness of a simple RAPID-3-like index compared to disease-specific BASDAI and ASDAS indices in patients with axial spondyloarthritis. RMD Open2016; 2: e000235.
40.
CastrejónIBergmanMJPincusT. MDHAQ/RAPID3 to recognize improvement over 2 months in usual care of patients with osteoarthritis, systemic lupus erythematosus, spondyloarthropathy, and gout, as well as rheumatoid arthritis. J Clin Rheumatol2013; 19: 169–174.
41.
KianiANStrandVFangHJaranillaJPetriM. Predictors of self-reported health-related quality of life in systemic lupus erythematosus. Rheumatology (Oxford)2013; 52: 1651–1657.
